Janssen Search
Search results
At Risk for Alzheimer’s disease?
Article Block Text: Article Type: Janssen Prevention Center At Risk for Alzheimer’s disease? Scientists at the Janssen Prevention Center have published their research into potential biomarkers of risk for Alzheimer’s disease, the most common form of ...
Trade Association Memberships
Our Trade Association Memberships At Janssen, we strive to discover and develop transformational medicines to help people around the world live longer, healthier and more productive lives. Sound and well-considered public policies are critical to ensure ...
Beverly L. Harrison
BEVERLY L. HARRISON SENIOR DIRECTOR PATIENT SUPPORT Beverly Harrison is responsible for leading the Patient Support Group reporting directly to the Chief Medical Officer at Janssen R&D, the research arm of Johnson & Johnson, focusing on developing ...
Contact Cardiovascular, Metabolism & Retina
Contact Cardiovascular, Metabolism & Retina at Janssen Thank you for your interest in learning more about our company. Interested in a potential collaboration with Janssen? Contact us with your idea. If you are a member of the media, and need to reach ...
Contact Janssen Neuroscience
Contact Neuroscience at Janssen Thank you for your interest in learning more about our company. Interested in a potential collaboration with Janssen? Contact us with your idea. If you are a member of the media, and need to reach our Research & ...
Margaret K. Yu, M.D.
MARGARET K. YU, M.D. VICE PRESIDENT DISEASE AREA STRONGHOLD LEADER, PROSTATE CANCER Margaret K. Yu, M.D. is Vice President, Prostate Cancer Disease Area Stronghold (DAS) Leader at Janssen Research & Development, LLC. Her role is to oversee all the ...
Yusri A. Elsayed, M.D., M.H.Sc., Ph.D.
YUSRI A. ELSAYED, M.D., M.H.Sc., Ph.D. SENIOR VICE PRESIDENT GLOBAL ONCOLOGY THERAPEUTIC AREA HEAD As Global Oncology Therapeutic Area Head for Johnson & Johnson, Yusri Elsayed, M.D., M.H.SC, Ph.D. is responsible for the discovery, development and ...
Kevin Wildenhaus, Ph.D.
As the Behavioral Science Lead for the Disease Interception Accelerator (DIA), Kevin Wildenhaus leads the behavioral science innovation and research efforts for the DIA and its venture focus areas. He is also heading work in perinatal depression to ...
Our Work
Article Type: Human Microbiome Institute Our Work We work with our partners to translate exciting ideas into therapies and other health solutions, and to create knowledge and resources that will advance the field as a whole. Our current collaborations ...
James Merson, Ph.D.
JAMES MERSON, Ph.D. GLOBAL HEAD INFECTIOUS DISEASES James Merson, Ph.D., is the Global Therapeutic Area Head for Infectious Diseases at Janssen Research & Development, L.L.C. He is a member of the Senior R&D Leadership Team, leading the global ...